Medical Devices Saudi Arabia

Saudi Arabia Deep Brain Stimulation Market Analysis, 2024–2034

Updated Reviewed by Vidhi Upadhyay

Saudi Arabia Deep Brain Stimulation Market Industry Trends and Forecast to 2034: Segmented by (Product, Indication, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

Saudi Arabia · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $29.0 Mn Placeholder estimate
Estimate 2025 $31.9 Mn 1.9% of the global market
Projected 2034 $76.6 Mn 139.7% Adds $44.6 Mn over 9 forecast years
CAGR 2025–2034 10.2% Faster than 50% of 173 Medical Devices markets here
Key players 5
  • Saudi Arabia is 1.92% of the global market.
  • In Middle East, the largest is Saudi Arabia (this report) at $31.9 Mn.
  • Fastest growing: Saudi Arabia (this report) at 10.2% a year.
  • Saudi Arabia ranks 1st of 2 by size in Middle East.

Market size projection

Saudi Arabia

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$44.6 Mn total, 2026–2034

Year-by-year market size, 2024–2034
Deep Brain Stimulation Market market size by year, Saudi Arabia
YearMarket sizeChange that yearSince 2025
2024 (estimate) $29.0 Mn — —
2025 (base) $31.9 Mn +$3.0 Mn —
2026 (forecast) $35.2 Mn +$3.3 Mn +10.2%
2027 (forecast) $38.8 Mn +$3.6 Mn +21.4%
2028 (forecast) $42.7 Mn +$4.0 Mn +33.8%
2029 (forecast) $47.1 Mn +$4.4 Mn +47.5%
2030 (forecast) $51.9 Mn +$4.8 Mn +62.5%
2031 (forecast) $57.2 Mn +$5.3 Mn +79.1%
2032 (forecast) $63.0 Mn +$5.8 Mn +97.4%
2033 (forecast) $69.5 Mn +$6.4 Mn +117.5%
2034 (forecast) $76.6 Mn +$7.1 Mn +139.7%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Same market worldwide

By geography

  1. Global $1.66 Bn
  2. North America $928.7 Mn
  3. US $608.6 Mn
  4. Europe $331.2 Mn
  5. APAC $317.0 Mn
  6. China $122.4 Mn
  7. Canada $116.2 Mn
  8. Japan $90.9 Mn
  9. Latin America $74.7 Mn
  10. Middle East $67.8 Mn
  11. Germany $56.4 Mn
  12. France $50.4 Mn
  13. Brazil $41.4 Mn
  14. Italy $39.7 Mn
  15. UK $38.2 Mn
  16. Ecuador $34.5 Mn
  17. Spain $33.4 Mn
  18. India $34.8 Mn
  19. Saudi Arabia (this report) $31.9 Mn
  20. Mexico $28.5 Mn
  21. Africa $24.3 Mn
  22. Australia $21.6 Mn
  23. New Zealand $15.7 Mn
  24. Russia $15.2 Mn
  25. South Africa $10.1 Mn
  26. UAE $9.7 Mn
  27. Egypt $4.2 Mn
  28. Philippines $4.0 Mn
  29. Hong Kong $2.7 Mn
  30. Malaysia $2.6 Mn
  31. Thailand $2.3 Mn
  32. Singapore $1.7 Mn
  33. Kenya $1.3 Mn

Report snapshot

Saudi Arabia Deep Brain Stimulation Market Analysis at a glance
Market size, 2025$31.9 Mn placeholder estimate
Forecast, 2034$76.6 Mn placeholder estimate
Growth (CAGR), 2025–203410.2% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsProduct, indication and end user (see all)
Key playersMedtronic, Boston Scientific Corporation, Abbott Laboratories, Newronika, SceneRay (see all)
Regulator in Saudi ArabiaSFDASource: Saudi Food and Drug Authority. Checked 14 Nov 2026.
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The Saudi Arabia Deep Brain Stimulation Market Analysis Executive Summary

Deep brain stimulation places thin wires in the brain connected to a pacemaker-like device, to treat Parkinson's, tremor and other conditions.

Key segments of the deep Brain Stimulation market include product (Single-Channel, Dual-Channel and Rechargeable) and indication (Parkinson's, Essential Tremor and Dystonia).

Bar chart: Saudi Arabia Deep Brain Stimulation market size, 2024–2034, placeholder estimates. $29.0 Mn in 2024, $31.9 Mn in 2025 and $76.6 Mn in 2034, 10.2% CAGR.
Saudi Arabia Deep Brain Stimulation market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

Saudi Arabia Deep Brain Stimulation Market Dynamics

Market Growth Drivers

An ageing population, more people living with brain and nerve diseases, better diagnosis and the first disease-modifying treatments are driving the deep Brain Stimulation market.

Opportunity

Biomarker-guided treatment, earlier diagnosis and new device-based therapies give the deep Brain Stimulation market strong room to grow.

Market Restraints

Hard-to-reach brain targets, high failure rates in trials, side effects and high prices for new therapies hold back the deep Brain Stimulation market.

Competitive Landscape for Deep Brain Stimulation Market in Saudi Arabia

The deep Brain Stimulation market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Deep Brain Stimulation Market in Saudi Arabia

Deep Brain Stimulation in Saudi Arabia: rules and payment

Medical devices need marketing authorisation from the Saudi Food and Drug Authority (SFDA).⁠[1] Citizens get free public care through the Ministry of Health, while most expatriate workers must have private health insurance, regulated by the Council of Health Insurance (CHI).⁠[2]

[1] Saudi Food and Drug Authority. Checked 14 Nov 2026.

[2] Council of Health Insurance. Checked 14 Nov 2026.

Policy changes and Reimbursement scenario

Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how deep Brain Stimulation products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in Saudi Arabia.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Deep Brain Stimulation right now, from free public sources.

Latest research 7,259 papers since 2021 (worldwide)

  1. Refractory Meige syndrome treated with bilateral globus pallidus internus deep brain stimulation. BMJ case reports, 2026
  2. Computer vision-derived gait-state tracking of acute treatment response in Parkinson's disease: external and prospective validation. NPJ Parkinson's disease, 2026
  3. Rehabilitation Strategies for Focal Hand Dystonia:A Narrative Review with Systematic Approach. The journal of medical investigation : JMI, 2026
  4. Continuous Recording of Local Field Potentials via Deep Brain Stimulation Electrodes in Parkinson's Disease:A Technical and Conceptual Review. The journal of medical investigation : JMI, 2026
  5. Flexible recording electrodes preliminarily reveal the brain-spinal circuit mechanism of spinal cord stimulation in the treatment of motor impairment in the mouse model of Parkinson's disease. Science China. Life sciences, 2026
Search all of them on PubMed (opens in a new tab)

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Deep Brain Stimulation in context

Saudi Arabia compared

  • Health spending per person: 1,825 US$ per person (2023). World: 1,317 US$ per person (2023). 2nd highest of the 9 countries we cover in Middle East.[1]
  • Doctors: 3.41 per 1,000 people (2023). World: 1.86 per 1,000 people (2022). Highest of the 9 countries we cover in Middle East.[2]
  • People aged 65 and over: 3.1% of people (2025). World: 10.4% of people (2025). 6th highest of the 9 countries we cover in Middle East.[3]

[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 14 Nov 2026.

[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 14 Nov 2026.

[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 15 Nov 2026.

Free data on this topic

Quick answers

Frequently asked questions

How big is the Deep Brain Stimulation market in Saudi Arabia?
Placeholder estimate: about $31.9 Mn in 2025, rising to about $76.6 Mn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Deep Brain Stimulation market in Saudi Arabia growing?
Placeholder estimate: about 10.2% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Deep Brain Stimulation market report cover?
The report splits the market by product (Single-Channel, Dual-Channel, Rechargeable, Adaptive Systems), indication (Parkinson's, Essential Tremor, Dystonia, Epilepsy and more) and end user (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Home Care Settings).
Who are the key players in the Deep Brain Stimulation market?
Key players include Medtronic, Boston Scientific Corporation, Abbott Laboratories, Newronika and SceneRay.
What is driving the Deep Brain Stimulation market?
An ageing population, more people living with brain and nerve diseases, better diagnosis and the first disease-modifying treatments are driving the deep Brain Stimulation market.
Who regulates Deep Brain Stimulation in Saudi Arabia?
Medical devices need marketing authorisation from the Saudi Food and Drug Authority (SFDA). Source: Saudi Food and Drug Authority. Checked 14 Nov 2026.
How is healthcare paid for in Saudi Arabia?
Citizens get free public care through the Ministry of Health, while most expatriate workers must have private health insurance, regulated by the Council of Health Insurance (CHI). Source: Council of Health Insurance. Checked 14 Nov 2026.
How much research is published on Deep Brain Stimulation?
PubMed lists 7,259 papers on Deep Brain Stimulation added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
Get a free sample The table of contents and sample pages. No payment needed. Request sample Consult Us Questions about Deep Brain Stimulation in Saudi Arabia? Our analysts can size it for your plan. Talk to us See the public data Health figures for every country, free. Open the Public Health Dashboard

From our blog

Brain Cancer Diagnosis: Imaging and New BiomarkersAbout 321,000 people were diagnosed with brain and nervous system tumours in 2022, and about 248,000 died… Alzheimer's Diagnosis: Blood Tests and Earlier Answers57 million people live with dementia. In May 2025 the US FDA cleared the first blood test used to help… Cannabis-Based Medicines: Science and RegulationThe FDA has approved one cannabis-derived medicine, Epidiolex, for rare epilepsies, and three synthetic…
Back to Catalogue
Keep exploring

Related Medical Devices reports in Saudi Arabia

See all
Same topic, other categories

Related on brain and nerves

See the topic